{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:02:19Z","timestamp":1791651739158,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.beem.2006.12.002","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T07:00:49Z","timestamp":1174546849000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Biochemistry of neuroendocrine tumours"],"prefix":"10.1016","volume":"21","author":[{"given":"Wouter W.","family":"de Herder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2006.12.002_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","article-title":"The diagnosis and medical management of advanced neuroendocrine tumors","volume":"25","author":"Kaltsas","year":"2004","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2006.12.002_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1677\/erc.0.0110019","article-title":"Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas","volume":"11","author":"de Herder","year":"2004","journal-title":"Endocrine-Related cancer"},{"key":"10.1016\/j.beem.2006.12.002_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(98)02286-7","article-title":"Carcinoid tumour","volume":"352","author":"Caplin","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.12.002_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumors","volume":"340","author":"Kulke","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.12.002_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bpg.2005.05.007","article-title":"Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome)","volume":"19","author":"de Herder","year":"2005","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"key":"10.1016\/j.beem.2006.12.002_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/003655202320621481","article-title":"Carcinoid heart disease: an update","volume":"236","author":"Quaedvlieg","year":"2002","journal-title":"Scandinavian Journal of Gastroenterology. Supplement"},{"key":"10.1016\/j.beem.2006.12.002_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.11226","article-title":"Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor","volume":"97","author":"Zuetenhorst","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2006.12.002_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ajcn\/42.4.639","article-title":"Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid","volume":"42","author":"Feldman","year":"1985","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.beem.2006.12.002_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/000456329503200117","article-title":"Measurement of 5-HIAA in urine","volume":"32","author":"Kema","year":"1995","journal-title":"Annals of Clinical Biochemistry"},{"key":"10.1016\/j.beem.2006.12.002_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/clinchem\/47.10.1811","article-title":"Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection","volume":"47","author":"Kema","year":"2001","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.beem.2006.12.002_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-4347(00)00341-8","article-title":"Clinical chemistry of serotonin and metabolites","volume":"747","author":"Kema","year":"2000","journal-title":"Journal of Chromatography. B, Biomedical Sciences and Applications"},{"key":"10.1016\/j.beem.2006.12.002_bib12","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/clinchem\/46.10.1588","article-title":"Discriminating capacity of indole markers in the diagnosis of carcinoid tumors","volume":"46","author":"Meijer","year":"2000","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.beem.2006.12.002_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/clinchem\/40.1.86","article-title":"Serotonin, catecholamines, histamine, and their metabolites in\u00a0urine, platelets, and tumor tissue of patients with carcinoid tumors","volume":"40","author":"Kema","year":"1994","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.beem.2006.12.002_bib14","first-page":"1582","article-title":"Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes","volume":"84","author":"Service","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199504273321707","article-title":"Hypoglycemic disorders","volume":"332","author":"Service","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.12.002_bib16","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jcem.85.11.6934","article-title":"The prolonged fast","volume":"85","author":"Service","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib17","first-page":"269","article-title":"Clinical review 42: hypoglycemias","volume":"76","author":"Service","year":"1993","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"supplement 1","key":"10.1016\/j.beem.2006.12.002_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000080735","article-title":"Insulinoma","volume":"80","author":"de Herder","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2006.12.002_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004280050476","article-title":"Adult hyperinsulinemic hypoglycemia not caused by an insulinoma: a report of two cases","volume":"436","author":"van der Wal","year":"2000","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.beem.2006.12.002_bib20","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1210\/jc.2005-0033","article-title":"Increasing serum betahydroxybutyrate concentrations during the 72-hour fast: evidence against hyperinsulinemic hypoglycemia","volume":"90","author":"Service","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0889-8529(05)70085-2","article-title":"Classification of hypoglycemic disorders","volume":"28","author":"Service","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2006.12.002_bib22","first-page":"1048","article-title":"Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma","volume":"78","author":"Kao","year":"1994","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib23","first-page":"448","article-title":"Insulin surrogates in insulinoma","volume":"77","author":"O'Brien","year":"1993","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/BF03347360","article-title":"Proinsulin-secreting neuroendocrine tumor of the pancreas","volume":"26","author":"Piovesan","year":"2003","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2006.12.002_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0168-8227(94)90153-8","article-title":"Assessment of immunoassays for insulin in diagnostic tests for insulinoma","volume":"26","author":"Shimizu","year":"1994","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.beem.2006.12.002_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cccn.2003.12.023","article-title":"Assessment of hyperinsulinaemia at the termination of the prolonged fast","volume":"342","author":"Wiesli","year":"2004","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.beem.2006.12.002_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/eje.0.1490413","article-title":"Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism","volume":"149","author":"Vezzosi","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.12.002_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11894-004-0067-5","article-title":"Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion","volume":"6","author":"Gibril","year":"2004","journal-title":"Current Gastroenterology Reports"},{"issue":"supplement 1","key":"10.1016\/j.beem.2006.12.002_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000080736","article-title":"Gastrinomas: advances in diagnosis and management","volume":"80","author":"Jensen","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2006.12.002_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.beem.2004.07.003","article-title":"Clinical endocrinology and metabolism. Gastrin","volume":"18","author":"Dockray","year":"2004","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.regpep.2004.08.027","article-title":"A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B","volume":"125","author":"Stridsberg","year":"2005","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.beem.2006.12.002_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.regpep.2004.03.017","article-title":"Chromogranin A as a determinant of midgut carcinoid tumour volume","volume":"120","author":"Kolby","year":"2004","journal-title":"Regulatory Peptides"},{"issue":"supplement 2","key":"10.1016\/j.beem.2006.12.002_bib33","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/annonc\/12.suppl_2.S69","article-title":"Clinical significance of blood chromogranin A measurement in neuroendocrine tumours","volume":"12","author":"Seregni","year":"2001","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.beem.2006.12.002_bib34","first-page":"2622","article-title":"Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones","volume":"82","author":"Nobels","year":"1997","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/joe.0.1440049","article-title":"Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours","volume":"144","author":"Stridsberg","year":"1995","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.12.002_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00004836-200608000-00003","article-title":"Gastrointestinal carcinoids: the evolution of diagnostic strategies","volume":"40","author":"Modlin","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"supplement 1","key":"10.1016\/j.beem.2006.12.002_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051853","article-title":"Tumor markers in neuroendocrine tumors","volume":"62","author":"Eriksson","year":"2000","journal-title":"Digestion"},{"key":"10.1016\/j.beem.2006.12.002_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/03009739509178905","article-title":"The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours","volume":"100","author":"Stridsberg","year":"1995","journal-title":"Upsala Journal of Medical Sciences"},{"key":"10.1016\/j.beem.2006.12.002_bib39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM198605013141803","article-title":"Secretion of chromogranin A by peptide-producing endocrine neoplasms","volume":"314","author":"O'Connor","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.12.002_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/edrv-12-2-181","article-title":"Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker","volume":"12","author":"Deftos","year":"1991","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2006.12.002_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/bjc.1998.635","article-title":"Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours","volume":"78","author":"Baudin","year":"1998","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.beem.2006.12.002_bib42","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8","article-title":"Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors","volume":"86","author":"Bajetta","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2006.12.002_bib43","first-page":"10","article-title":"Cardiovascular abnormalities in patients with a carcinoid syndrome","volume":"60","author":"Meijer","year":"2002","journal-title":"The Netherlands Journal of Medicine"},{"key":"10.1016\/j.beem.2006.12.002_bib44","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1373\/49.4.586","article-title":"Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas","volume":"49","author":"Meijer","year":"2003","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.beem.2006.12.002_bib45","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1136\/gut.2006.092320","article-title":"Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours","volume":"55","author":"Turner","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.beem.2006.12.002_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF03350903","article-title":"Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors","volume":"27","author":"Panzuto","year":"2004","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2006.12.002_bib47","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2002-021842","article-title":"Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma","volume":"88","author":"Corbetta","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib48","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1210\/jc.2003-032118","article-title":"Malignant gastric ghrelinoma with hyperghrelinemia","volume":"89","author":"Tsolakis","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.12.002_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-2006-925129","article-title":"Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas","volume":"38","author":"Pavel","year":"2006","journal-title":"Hormone and Metabolic Research"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:37:00Z","timestamp":1761496620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X06001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1521690X06001114"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2006.12.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemistry of neuroendocrine tumours","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2006.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}